 | • レポートコード：MRC23Q38062 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、67ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の新型コロナ抗ウイルス経口薬品市場について調査・分析し、世界の新型コロナ抗ウイルス経口薬品市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（錠剤、カプセル）、用途別セグメント分析（病院、クリニック）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Merck and Ridgebackなどが含まれています。世界の新型コロナ抗ウイルス経口薬品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、新型コロナ抗ウイルス経口薬品市場規模を推定する際に考慮しました。本レポートは、新型コロナ抗ウイルス経口薬品の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、新型コロナ抗ウイルス経口薬品に関するビジネス上の意思決定に役立てることを目的としています。 ・新型コロナ抗ウイルス経口薬品市場の概要 - 製品の定義 - 新型コロナ抗ウイルス経口薬品のタイプ別セグメント - 世界の新型コロナ抗ウイルス経口薬品市場規模：タイプ別分析（錠剤、カプセル） - 新型コロナ抗ウイルス経口薬品の用途別セグメント - 世界の新型コロナ抗ウイルス経口薬品市場規模：用途別分析（病院、クリニック） - 世界の新型コロナ抗ウイルス経口薬品市場規模予測（2018年-2029年） - 新型コロナ抗ウイルス経口薬品の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 新型コロナ抗ウイルス経口薬品市場の競争状況およびトレンド ・新型コロナ抗ウイルス経口薬品の地域別市場規模 - 北米の新型コロナ抗ウイルス経口薬品市場規模（2018年-2029年） - アメリカの新型コロナ抗ウイルス経口薬品市場規模（2018年-2029年） - ヨーロッパの新型コロナ抗ウイルス経口薬品市場規模（2018年-2029年） - アジア太平洋の新型コロナ抗ウイルス経口薬品市場規模（2018年-2029年） - 中国の新型コロナ抗ウイルス経口薬品市場規模（2018年-2029年） - 日本の新型コロナ抗ウイルス経口薬品市場規模（2018年-2029年） - 韓国の新型コロナ抗ウイルス経口薬品市場規模（2018年-2029年） - インドの新型コロナ抗ウイルス経口薬品市場規模（2018年-2029年） - オーストラリアの新型コロナ抗ウイルス経口薬品市場規模（2018年-2029年） - 中南米の新型コロナ抗ウイルス経口薬品市場規模（2018年-2029年） - 中東・アフリカの新型コロナ抗ウイルス経口薬品市場規模（2018年-2029年） ・タイプ別セグメント：錠剤、カプセル - 世界の新型コロナ抗ウイルス経口薬品のタイプ別販売量（2018年-2023年） - 世界の新型コロナ抗ウイルス経口薬品のタイプ別売上（2018年-2023年） - 世界の新型コロナ抗ウイルス経口薬品のタイプ別価格 ・用途別セグメント：病院、クリニック - 世界の新型コロナ抗ウイルス経口薬品の用途別販売量（2018年-2023年） - 世界の新型コロナ抗ウイルス経口薬品の用途別売上（2018年-2023年） - 世界の新型コロナ抗ウイルス経口薬品の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Merck and Ridgeback ・産業チェーンと販売チャネルの分析 - 新型コロナ抗ウイルス経口薬品産業チェーン分析 - 新型コロナ抗ウイルス経口薬品の主要原材料 - 新型コロナ抗ウイルス経口薬品の販売チャネル - 新型コロナ抗ウイルス経口薬品のディストリビューター - 新型コロナ抗ウイルス経口薬品の主要顧客 ・新型コロナ抗ウイルス経口薬品市場ダイナミクス - 新型コロナ抗ウイルス経口薬品の業界動向 - 新型コロナ抗ウイルス経口薬品市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Oral COVID-19 Antiviral Medicine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Oral COVID-19 Antiviral Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Oral COVID-19 Antiviral Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Oral COVID-19 Antiviral Medicine include Merck and Ridgeback. etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral COVID-19 Antiviral Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral COVID-19 Antiviral Medicine.
The Oral COVID-19 Antiviral Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oral COVID-19 Antiviral Medicine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral COVID-19 Antiviral Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Merck and Ridgeback
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral COVID-19 Antiviral Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral COVID-19 Antiviral Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Oral COVID-19 Antiviral Medicine Market Overview
1.1 Product Overview and Scope of Oral COVID-19 Antiviral Medicine
1.2 Oral COVID-19 Antiviral Medicine Segment by Type
1.2.1 Global Oral COVID-19 Antiviral Medicine Market Value Comparison by Type (2023-2029)
1.2.2 Tablet
1.2.3 Capsule
1.3 Oral COVID-19 Antiviral Medicine Segment by Application
1.3.1 Global Oral COVID-19 Antiviral Medicine Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Oral COVID-19 Antiviral Medicine Market Size Estimates and Forecasts
1.4.1 Global Oral COVID-19 Antiviral Medicine Revenue 2018-2029
1.4.2 Global Oral COVID-19 Antiviral Medicine Sales 2018-2029
1.4.3 Global Oral COVID-19 Antiviral Medicine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral COVID-19 Antiviral Medicine Market Competition by Manufacturers
2.1 Global Oral COVID-19 Antiviral Medicine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral COVID-19 Antiviral Medicine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral COVID-19 Antiviral Medicine Average Price by Manufacturers (2018-2023)
2.4 Global Oral COVID-19 Antiviral Medicine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral COVID-19 Antiviral Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral COVID-19 Antiviral Medicine, Product Type & Application
2.7 Oral COVID-19 Antiviral Medicine Market Competitive Situation and Trends
2.7.1 Oral COVID-19 Antiviral Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral COVID-19 Antiviral Medicine Players Market Share by Revenue
2.7.3 Global Oral COVID-19 Antiviral Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral COVID-19 Antiviral Medicine Retrospective Market Scenario by Region
3.1 Global Oral COVID-19 Antiviral Medicine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral COVID-19 Antiviral Medicine Global Oral COVID-19 Antiviral Medicine Sales by Region: 2018-2029
3.2.1 Global Oral COVID-19 Antiviral Medicine Sales by Region: 2018-2023
3.2.2 Global Oral COVID-19 Antiviral Medicine Sales by Region: 2024-2029
3.3 Global Oral COVID-19 Antiviral Medicine Global Oral COVID-19 Antiviral Medicine Revenue by Region: 2018-2029
3.3.1 Global Oral COVID-19 Antiviral Medicine Revenue by Region: 2018-2023
3.3.2 Global Oral COVID-19 Antiviral Medicine Revenue by Region: 2024-2029
3.4 North America Oral COVID-19 Antiviral Medicine Market Facts & Figures by Country
3.4.1 North America Oral COVID-19 Antiviral Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral COVID-19 Antiviral Medicine Sales by Country (2018-2029)
3.4.3 North America Oral COVID-19 Antiviral Medicine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral COVID-19 Antiviral Medicine Market Facts & Figures by Country
3.5.1 Europe Oral COVID-19 Antiviral Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral COVID-19 Antiviral Medicine Sales by Country (2018-2029)
3.5.3 Europe Oral COVID-19 Antiviral Medicine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral COVID-19 Antiviral Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Oral COVID-19 Antiviral Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral COVID-19 Antiviral Medicine Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral COVID-19 Antiviral Medicine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Oral COVID-19 Antiviral Medicine Market Facts & Figures by Country
3.7.1 Latin America Oral COVID-19 Antiviral Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral COVID-19 Antiviral Medicine Sales by Country (2018-2029)
3.7.3 Latin America Oral COVID-19 Antiviral Medicine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral COVID-19 Antiviral Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral COVID-19 Antiviral Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral COVID-19 Antiviral Medicine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral COVID-19 Antiviral Medicine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral COVID-19 Antiviral Medicine Sales by Type (2018-2029)
4.1.1 Global Oral COVID-19 Antiviral Medicine Sales by Type (2018-2023)
4.1.2 Global Oral COVID-19 Antiviral Medicine Sales by Type (2024-2029)
4.1.3 Global Oral COVID-19 Antiviral Medicine Sales Market Share by Type (2018-2029)
4.2 Global Oral COVID-19 Antiviral Medicine Revenue by Type (2018-2029)
4.2.1 Global Oral COVID-19 Antiviral Medicine Revenue by Type (2018-2023)
4.2.2 Global Oral COVID-19 Antiviral Medicine Revenue by Type (2024-2029)
4.2.3 Global Oral COVID-19 Antiviral Medicine Revenue Market Share by Type (2018-2029)
4.3 Global Oral COVID-19 Antiviral Medicine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral COVID-19 Antiviral Medicine Sales by Application (2018-2029)
5.1.1 Global Oral COVID-19 Antiviral Medicine Sales by Application (2018-2023)
5.1.2 Global Oral COVID-19 Antiviral Medicine Sales by Application (2024-2029)
5.1.3 Global Oral COVID-19 Antiviral Medicine Sales Market Share by Application (2018-2029)
5.2 Global Oral COVID-19 Antiviral Medicine Revenue by Application (2018-2029)
5.2.1 Global Oral COVID-19 Antiviral Medicine Revenue by Application (2018-2023)
5.2.2 Global Oral COVID-19 Antiviral Medicine Revenue by Application (2024-2029)
5.2.3 Global Oral COVID-19 Antiviral Medicine Revenue Market Share by Application (2018-2029)
5.3 Global Oral COVID-19 Antiviral Medicine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck and Ridgeback
6.1.1 Merck and Ridgeback Corporation Information
6.1.2 Merck and Ridgeback Description and Business Overview
6.1.3 Merck and Ridgeback Oral COVID-19 Antiviral Medicine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck and Ridgeback Oral COVID-19 Antiviral Medicine Product Portfolio
6.1.5 Merck and Ridgeback Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral COVID-19 Antiviral Medicine Industry Chain Analysis
7.2 Oral COVID-19 Antiviral Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral COVID-19 Antiviral Medicine Production Mode & Process
7.4 Oral COVID-19 Antiviral Medicine Sales and Marketing
7.4.1 Oral COVID-19 Antiviral Medicine Sales Channels
7.4.2 Oral COVID-19 Antiviral Medicine Distributors
7.5 Oral COVID-19 Antiviral Medicine Customers
8 Oral COVID-19 Antiviral Medicine Market Dynamics
8.1 Oral COVID-19 Antiviral Medicine Industry Trends
8.2 Oral COVID-19 Antiviral Medicine Market Drivers
8.3 Oral COVID-19 Antiviral Medicine Market Challenges
8.4 Oral COVID-19 Antiviral Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer